NASDAQ:NRXP | Cash Flow Statement | NRX Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$16.52M
2026-03-31-$1.43M$63,000.00-$4.3M-$213,000.00$3.42M
2025-12-31$360,000.00-$3.71M-$249,000.00$4.58M
2025-09-30-$5.89M
2025-06-30-$17.58M
2025-03-31-$5.51M$1,000.00-$3.48M$0.00$7.59M
2024-12-31-$9.08M-$2.1M$0.00$1.9M
2024-09-30-$1.62M
2024-06-30-$7.9M
2024-03-31-$6.53M-$3.67M$0.00$395,000.00
2023-12-31-$4.33M-$3.19M$1,000.00-$1.12M
2023-09-30-$6.06M
2023-06-30-$8.72M
2023-03-31-$5.51M-$6.09M-$4,000.00$2.55M
2022-12-31-$10.24M-$8.32M$1,000.00$10.12M
2022-09-30-$9.08M
2022-06-30-$6.98M
2022-03-31-$13.45M-$10.38M-$3,000.00$22.98M
2021-12-31-$30.41M-$11.28M$0.00$1,000.00
2021-09-30-$37.05M
2021-06-30-$117,000.00
2021-03-31-$25.49M-$3.02M$0.00$14.43M
2020-12-31-$45.13M-$406,706.00-$26.21M$980,370.00
2020-09-30-$5.16M
2020-06-30$102,287.00
2020-03-31-$1.59M-$76,434.00$25.93M$26M-$25.77M
2019-12-31-$14,754.00-$262,074.00$9.64M-$9.58M
2019-09-30$59,195.00
2019-06-30$176,021.00
2019-03-31$187,965.00-$297,696.00-$508,207.00$0.00$796,642.00
2018-12-31$29,139.00-$70,884.00-$684,907.00$690,000.00
2018-09-30$28,084.00
2018-06-30-$6,602.00
2018-03-31$15,481.00-$197,817.00$23,134.00-$7,500.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$28.62M-$14.11M-$2.81M$23.28M
2024-12-31-$25.13M-$10.64M$0.00$7.49M
2023-12-31-$30.15M-$21.66M-$3,000.00$6.2M
2022-12-31-$39.75M-$39.76M-$10,000.00$32.21M
2021-12-31-$93.06M-$37.7M-$7,000.00$63.46M
2020-12-31-$51.78M-$2.27M-$2,000.00$3.25M
2019-12-31$408,427.00-$792,731.00$40.25M-$39.46M
2018-12-31$66,101.00-$473,187.00-$647,392.00$682,500.00